Pillar Risk-Based Treatment for Chronic Kidney Disease in People With Type 2 Diabetes: A Narrative Review.

Diabetes Ther · 2025 · PMC12579093 · PMID 40971126

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

did not reach statistical significanceP = 0.08so close (0.05 < p ≤ 0.1)

Cardiovascular death occurred in 421 (4.4%) individuals receiving finerenone and 471 (5.0%) receiving placebo, but did not reach statistical significance (HR, 0.89; 95% CI 0.78–1.01; P = 0.08) [ 38 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.